Kenneth Truitt
No más puestos en curso
Perfil
Kenneth Truitt served as Chief Medical Officer at Aquestive Therapeutics, Inc., ImmusanT, Inc., and Venthera, Inc.
Antiguos cargos conocidos de Kenneth Truitt.
| Empresas | Cargo | Fin |
|---|---|---|
Venthera, Inc.
 Venthera, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Venthera, Inc. develops biopharmaceuticals. The company is based in Palo Alto, CA. The company was founded by José Baselga. | Director Técnico/Científico/I+D | - |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | - |
| AQUESTIVE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Venthera, Inc.
Venthera, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Venthera, Inc. develops biopharmaceuticals. The company is based in Palo Alto, CA. The company was founded by José Baselga. | Health Technology |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kenneth Truitt
